UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
92 hedge funds and large institutions have $122M invested in Unity Biotechnology in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 27 reducing their positions, and 10 closing their positions.
Holders
92
Holders Change
+7
Holders Change %
+8.24%
% of All Funds
1.62%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
17
Increased
20
Reduced
27
Closed
10
Calls
$1.03M
Puts
$761K
Net Calls
+$268K
Net Calls Change
+$146K
Top Buyers
| 1 |
1
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$3.45M |
| 2 |
2
Two Sigma Investments
New York
|
$727K |
| 3 |
3
Axa
Paris,
France
|
$709K |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$3.33M |
| 5 |
5
Two Sigma Advisers
New York
|
$398K |
